Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
3.18M
-
Number of holders
-
94
-
Total 13F shares, excl. options
-
43.7M
-
Shares change
-
-1.5M
-
Total reported value, excl. options
-
$278M
-
Value change
-
-$20.4M
-
Put/Call ratio
-
0.76
-
Number of buys
-
54
-
Number of sells
-
-40
-
Price
-
$6.35
Significant Holders of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) as of Q4 2021
115 filings reported holding PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share as of Q4 2021.
Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) has 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.7M shares
.
Largest 10 shareholders include ORBIMED ADVISORS LLC (6.96M shares), FRAZIER MANAGEMENT LLC (5.01M shares), Versant Venture Management, LLC (4.96M shares), BlackRock Inc. (3.49M shares), Deep Track Capital, LP (3.22M shares), New Leaf Venture Partners, L.L.C. (2.5M shares), VANGUARD GROUP INC (1.92M shares), Woodline Partners LP (1.92M shares), FMR LLC (1.79M shares), and MORGAN STANLEY (1.55M shares).
This table shows the top 94 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.